EIDX - Eidos Therapeutics EPS misses by $0.07 May, 08 2020 04:33 PM Eidos Therapeutics Inc. Eidos Therapeutics (NASDAQ:EIDX): Q1 GAAP EPS of -$0.60 misses by $0.07.Cash and cash equivalents totaled $196.5MPress ReleaseMore news on: Eidos Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,